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Tyrosine kinase inhibitors such as imatinib (IM), have significantly improved treatment 
of chronic myelogenous leukemia (CML). Yet, most patients are not cured for 
undetermined reasons. In this talk we will describe our recent work on modeling the 
autologous immune response to CML. We will also discuss our previous results on 
cancer vaccines, drug resistance, and the dynamics of hematopoietic stem cells. 
